Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aldosterone | 65 | 2024 | 877 | 8.490 |
Why?
|
Receptors, Mineralocorticoid | 22 | 2024 | 164 | 4.020 |
Why?
|
Spironolactone | 19 | 2023 | 382 | 2.750 |
Why?
|
Hypoglycemia | 13 | 2023 | 861 | 2.320 |
Why?
|
Sodium, Dietary | 20 | 2020 | 418 | 2.000 |
Why?
|
Hypertension | 36 | 2024 | 8479 | 1.980 |
Why?
|
Angiotensin II | 29 | 2023 | 881 | 1.940 |
Why?
|
Renin-Angiotensin System | 24 | 2022 | 758 | 1.940 |
Why?
|
Diet, Sodium-Restricted | 16 | 2023 | 287 | 1.760 |
Why?
|
Hyperaldosteronism | 6 | 2021 | 240 | 1.720 |
Why?
|
Blood Pressure | 49 | 2024 | 8551 | 1.690 |
Why?
|
Caveolin 1 | 12 | 2020 | 263 | 1.680 |
Why?
|
Baroreflex | 5 | 2023 | 146 | 1.510 |
Why?
|
Insulin Resistance | 22 | 2024 | 3864 | 1.490 |
Why?
|
Blood Glucose | 23 | 2023 | 6254 | 1.240 |
Why?
|
Glucose Clamp Technique | 10 | 2023 | 266 | 1.170 |
Why?
|
Adrenal Glands | 8 | 2020 | 546 | 1.130 |
Why?
|
NG-Nitroarginine Methyl Ester | 12 | 2023 | 254 | 1.090 |
Why?
|
Fibromyalgia | 8 | 2015 | 388 | 1.070 |
Why?
|
Sodium Chloride, Dietary | 14 | 2024 | 281 | 1.060 |
Why?
|
Autonomic Nervous System | 6 | 2022 | 672 | 1.050 |
Why?
|
Receptor, Angiotensin, Type 1 | 6 | 2011 | 152 | 1.020 |
Why?
|
Renin | 21 | 2024 | 642 | 0.950 |
Why?
|
Neurosecretory Systems | 4 | 2009 | 231 | 0.900 |
Why?
|
Rats, Wistar | 24 | 2023 | 1892 | 0.890 |
Why?
|
Obesity | 22 | 2024 | 12746 | 0.850 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2017 | 281 | 0.830 |
Why?
|
Cardiovascular System | 5 | 2015 | 831 | 0.810 |
Why?
|
Calmodulin-Binding Proteins | 7 | 2021 | 250 | 0.810 |
Why?
|
Insulin | 22 | 2023 | 6582 | 0.810 |
Why?
|
Food Preservatives | 1 | 2021 | 11 | 0.810 |
Why?
|
Zona Glomerulosa | 8 | 2021 | 86 | 0.790 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2023 | 11726 | 0.760 |
Why?
|
Cosyntropin | 1 | 2020 | 33 | 0.740 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2020 | 257 | 0.720 |
Why?
|
Oxytocin | 3 | 2018 | 394 | 0.690 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2023 | 3255 | 0.690 |
Why?
|
Cardiovascular Diseases | 15 | 2023 | 15160 | 0.690 |
Why?
|
Aortic Rupture | 1 | 2022 | 312 | 0.660 |
Why?
|
Glucose | 14 | 2021 | 4398 | 0.660 |
Why?
|
Adipose Tissue | 10 | 2017 | 3280 | 0.630 |
Why?
|
Coronary Circulation | 3 | 2018 | 1572 | 0.620 |
Why?
|
Polymorphism, Single Nucleotide | 14 | 2023 | 15520 | 0.610 |
Why?
|
Epinephrine | 13 | 2023 | 792 | 0.590 |
Why?
|
Aortic Aneurysm | 1 | 2022 | 644 | 0.590 |
Why?
|
Myocardium | 10 | 2021 | 4772 | 0.550 |
Why?
|
Pancreatitis | 11 | 1999 | 1092 | 0.540 |
Why?
|
Gene Frequency | 11 | 2018 | 3587 | 0.530 |
Why?
|
Dental Caries | 2 | 2017 | 415 | 0.520 |
Why?
|
Potassium | 7 | 2020 | 1336 | 0.510 |
Why?
|
Hydrocortisone | 14 | 2020 | 1826 | 0.510 |
Why?
|
Male | 155 | 2024 | 350115 | 0.510 |
Why?
|
Endothelium, Vascular | 4 | 2013 | 4459 | 0.500 |
Why?
|
Lectins | 1 | 2017 | 513 | 0.480 |
Why?
|
Adrenocorticotropic Hormone | 10 | 2015 | 648 | 0.460 |
Why?
|
Adult | 106 | 2024 | 214052 | 0.460 |
Why?
|
Dyslipidemias | 2 | 2020 | 849 | 0.460 |
Why?
|
Interleukin-6 | 5 | 2023 | 3203 | 0.450 |
Why?
|
Estradiol | 5 | 2012 | 2020 | 0.440 |
Why?
|
Lipid Metabolism | 5 | 2016 | 1889 | 0.440 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 818 | 0.440 |
Why?
|
Vagus Nerve | 1 | 2015 | 439 | 0.440 |
Why?
|
Kidney | 12 | 2023 | 7184 | 0.430 |
Why?
|
Female | 130 | 2024 | 380193 | 0.430 |
Why?
|
Norepinephrine | 10 | 2010 | 909 | 0.430 |
Why?
|
Pericardium | 1 | 2017 | 667 | 0.430 |
Why?
|
Abortion, Spontaneous | 1 | 2018 | 544 | 0.430 |
Why?
|
Humans | 191 | 2024 | 744366 | 0.420 |
Why?
|
Apolipoproteins E | 2 | 2018 | 1438 | 0.420 |
Why?
|
Heart | 5 | 2019 | 4464 | 0.420 |
Why?
|
Hydrochlorothiazide | 2 | 2014 | 98 | 0.410 |
Why?
|
Middle Aged | 100 | 2024 | 213390 | 0.410 |
Why?
|
RNA, Messenger | 27 | 2023 | 13035 | 0.410 |
Why?
|
Stress, Psychological | 4 | 2012 | 4245 | 0.400 |
Why?
|
Corticotropin-Releasing Hormone | 7 | 2014 | 369 | 0.400 |
Why?
|
Angiotensinogen | 3 | 2021 | 163 | 0.390 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2008 | 1115 | 0.390 |
Why?
|
Arteritis | 2 | 2024 | 159 | 0.380 |
Why?
|
Cardiovascular Physiological Phenomena | 2 | 2009 | 235 | 0.380 |
Why?
|
Adiponectin | 3 | 2017 | 1101 | 0.380 |
Why?
|
Enalapril | 3 | 2018 | 327 | 0.380 |
Why?
|
Microcirculation | 2 | 2014 | 1287 | 0.370 |
Why?
|
Rats | 29 | 2023 | 24252 | 0.370 |
Why?
|
Double-Blind Method | 13 | 2020 | 12025 | 0.370 |
Why?
|
Vasoconstriction | 7 | 2015 | 597 | 0.370 |
Why?
|
Signal Transduction | 20 | 2021 | 23404 | 0.370 |
Why?
|
Nerve Tissue Proteins | 7 | 2021 | 4463 | 0.360 |
Why?
|
Adrenalectomy | 3 | 2021 | 341 | 0.360 |
Why?
|
Animals | 84 | 2023 | 168768 | 0.360 |
Why?
|
Diuretics | 3 | 2014 | 591 | 0.360 |
Why?
|
Diabetic Nephropathies | 2 | 2007 | 984 | 0.350 |
Why?
|
Helicobacter pylori | 5 | 1999 | 383 | 0.340 |
Why?
|
Pituitary-Adrenal System | 3 | 2015 | 553 | 0.340 |
Why?
|
Helicobacter Infections | 5 | 1999 | 387 | 0.340 |
Why?
|
Factor V | 1 | 2010 | 178 | 0.340 |
Why?
|
Cross-Over Studies | 4 | 2021 | 2029 | 0.340 |
Why?
|
Histone Demethylases | 4 | 2019 | 321 | 0.330 |
Why?
|
Genetic Predisposition to Disease | 8 | 2021 | 17446 | 0.330 |
Why?
|
Promoter Regions, Genetic | 4 | 2017 | 5867 | 0.330 |
Why?
|
Renal Plasma Flow | 2 | 2021 | 30 | 0.320 |
Why?
|
Gene Expression Regulation | 14 | 2018 | 12073 | 0.320 |
Why?
|
Diet, Reducing | 4 | 2004 | 462 | 0.310 |
Why?
|
Heart Rate | 4 | 2022 | 4092 | 0.310 |
Why?
|
Simvastatin | 2 | 2023 | 360 | 0.300 |
Why?
|
Vasodilation | 6 | 2021 | 944 | 0.300 |
Why?
|
Membrane Proteins | 9 | 2021 | 7882 | 0.300 |
Why?
|
Oxidoreductases, N-Demethylating | 3 | 2012 | 115 | 0.300 |
Why?
|
Fenfluramine | 2 | 1998 | 59 | 0.300 |
Why?
|
Sodium | 7 | 2024 | 1622 | 0.300 |
Why?
|
Nitric Oxide | 8 | 2015 | 2132 | 0.300 |
Why?
|
Adiposity | 4 | 2018 | 1806 | 0.300 |
Why?
|
Sex Factors | 8 | 2021 | 10400 | 0.300 |
Why?
|
Young Adult | 24 | 2024 | 56429 | 0.300 |
Why?
|
Lipolysis | 4 | 2002 | 210 | 0.300 |
Why?
|
HIV Infections | 11 | 2024 | 16715 | 0.290 |
Why?
|
Pancreas | 10 | 1999 | 1687 | 0.290 |
Why?
|
Appetite Depressants | 2 | 1998 | 110 | 0.290 |
Why?
|
Antihypertensive Agents | 4 | 2013 | 2047 | 0.280 |
Why?
|
Inflammation | 7 | 2019 | 10637 | 0.280 |
Why?
|
Hemodynamics | 6 | 2021 | 4196 | 0.280 |
Why?
|
Alleles | 10 | 2021 | 6933 | 0.280 |
Why?
|
Proteinuria | 2 | 2006 | 658 | 0.270 |
Why?
|
Sympathetic Nervous System | 4 | 2022 | 513 | 0.270 |
Why?
|
Body Mass Index | 17 | 2018 | 12721 | 0.270 |
Why?
|
Adolescent | 30 | 2024 | 85779 | 0.270 |
Why?
|
Receptors, Cell Surface | 6 | 2016 | 2865 | 0.270 |
Why?
|
Muscle, Smooth, Vascular | 5 | 2013 | 1504 | 0.270 |
Why?
|
Nitric Oxide Synthase Type III | 6 | 2013 | 689 | 0.260 |
Why?
|
Hyperinsulinism | 3 | 2010 | 415 | 0.260 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1741 | 0.260 |
Why?
|
Memory | 1 | 2015 | 2174 | 0.260 |
Why?
|
Caloric Restriction | 2 | 2018 | 302 | 0.260 |
Why?
|
Social Behavior | 1 | 2012 | 1127 | 0.260 |
Why?
|
Cholelithiasis | 3 | 1998 | 414 | 0.260 |
Why?
|
Poland | 3 | 2017 | 184 | 0.260 |
Why?
|
Prediabetic State | 2 | 2024 | 499 | 0.260 |
Why?
|
Estrogen Receptor beta | 2 | 2021 | 175 | 0.260 |
Why?
|
Aging | 5 | 2012 | 8664 | 0.250 |
Why?
|
Intra-Abdominal Fat | 3 | 2015 | 591 | 0.240 |
Why?
|
Hypoglycemic Agents | 6 | 2023 | 2873 | 0.240 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 845 | 0.240 |
Why?
|
Diabetes Mellitus | 6 | 2018 | 5749 | 0.240 |
Why?
|
Hormones | 5 | 2014 | 889 | 0.230 |
Why?
|
Up-Regulation | 5 | 2015 | 4222 | 0.230 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6486 | 0.230 |
Why?
|
Sleep Deprivation | 1 | 2010 | 832 | 0.230 |
Why?
|
Hyperglycemia | 4 | 2020 | 1373 | 0.220 |
Why?
|
Fibrinogen | 2 | 1998 | 894 | 0.220 |
Why?
|
Aged | 42 | 2024 | 163288 | 0.220 |
Why?
|
Reference Values | 7 | 2010 | 4982 | 0.220 |
Why?
|
Heart Diseases | 2 | 2009 | 2789 | 0.220 |
Why?
|
Cholesterol | 6 | 2020 | 2919 | 0.210 |
Why?
|
Weight Loss | 3 | 2000 | 2625 | 0.210 |
Why?
|
Hippocampus | 1 | 2015 | 3675 | 0.210 |
Why?
|
Circadian Rhythm | 4 | 2020 | 2624 | 0.210 |
Why?
|
Homeostasis | 6 | 2020 | 3339 | 0.210 |
Why?
|
Calcium Channels, L-Type | 1 | 2023 | 240 | 0.210 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1203 | 0.200 |
Why?
|
Aorta | 5 | 2015 | 2062 | 0.200 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2021 | 703 | 0.200 |
Why?
|
Leukocyte Rolling | 1 | 2021 | 72 | 0.200 |
Why?
|
Triglycerides | 7 | 2016 | 2453 | 0.200 |
Why?
|
Body Weight | 6 | 2013 | 4671 | 0.200 |
Why?
|
Urea | 4 | 1999 | 450 | 0.200 |
Why?
|
Mice | 39 | 2021 | 81201 | 0.200 |
Why?
|
Liver | 10 | 2016 | 7475 | 0.200 |
Why?
|
C-Peptide | 2 | 2020 | 419 | 0.200 |
Why?
|
Models, Animal | 4 | 2013 | 2173 | 0.190 |
Why?
|
Cytochrome P-450 Enzyme System | 3 | 1994 | 419 | 0.190 |
Why?
|
Dyspepsia | 2 | 1999 | 116 | 0.190 |
Why?
|
Human Growth Hormone | 2 | 2003 | 683 | 0.190 |
Why?
|
Pravastatin | 1 | 2023 | 395 | 0.190 |
Why?
|
Thyrotropin | 3 | 2021 | 849 | 0.190 |
Why?
|
Propionates | 1 | 2021 | 169 | 0.190 |
Why?
|
Hormone Antagonists | 2 | 2000 | 108 | 0.190 |
Why?
|
Macrophages, Peritoneal | 1 | 2021 | 251 | 0.190 |
Why?
|
Arachidonic Acids | 1 | 2021 | 299 | 0.180 |
Why?
|
Transforming Growth Factor beta | 5 | 2001 | 2007 | 0.180 |
Why?
|
Stroke | 1 | 2023 | 9981 | 0.180 |
Why?
|
Risk Factors | 24 | 2023 | 72296 | 0.180 |
Why?
|
Haplotypes | 4 | 2017 | 2779 | 0.180 |
Why?
|
Muscle Fatigue | 1 | 2000 | 82 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2013 | 10943 | 0.180 |
Why?
|
Food, Formulated | 1 | 2000 | 109 | 0.180 |
Why?
|
Social Support | 1 | 2009 | 2118 | 0.180 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2003 | 2016 | 0.180 |
Why?
|
Gadolinium DTPA | 5 | 2013 | 836 | 0.170 |
Why?
|
DMF Index | 2 | 2017 | 90 | 0.170 |
Why?
|
Transforming Growth Factor alpha | 4 | 2001 | 135 | 0.170 |
Why?
|
Aminopeptidases | 1 | 2019 | 88 | 0.170 |
Why?
|
Second Messenger Systems | 4 | 1999 | 206 | 0.170 |
Why?
|
Breath Tests | 4 | 2002 | 280 | 0.170 |
Why?
|
Vasoconstrictor Agents | 7 | 2015 | 642 | 0.170 |
Why?
|
Brachial Artery | 2 | 2013 | 369 | 0.170 |
Why?
|
Chronobiology Disorders | 1 | 2020 | 74 | 0.170 |
Why?
|
C-Reactive Protein | 2 | 2023 | 3778 | 0.170 |
Why?
|
Energy Metabolism | 2 | 2020 | 2897 | 0.170 |
Why?
|
Adipokines | 2 | 2013 | 320 | 0.160 |
Why?
|
Serotonin Antagonists | 1 | 1999 | 144 | 0.160 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2019 | 298 | 0.160 |
Why?
|
Renal Artery | 1 | 2000 | 399 | 0.160 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 1998 | 45 | 0.160 |
Why?
|
Mice, Knockout | 14 | 2020 | 14561 | 0.160 |
Why?
|
Adenylate Kinase | 1 | 2018 | 99 | 0.160 |
Why?
|
Pituitary Gland | 2 | 1998 | 665 | 0.160 |
Why?
|
Glycerol | 5 | 2007 | 278 | 0.160 |
Why?
|
HIV | 2 | 2023 | 1604 | 0.150 |
Why?
|
Tetanus Toxoid | 1 | 1998 | 193 | 0.150 |
Why?
|
Physical Endurance | 1 | 2000 | 370 | 0.150 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1999 | 314 | 0.150 |
Why?
|
Hypertension, Renal | 2 | 2021 | 177 | 0.150 |
Why?
|
Endocrine System | 1 | 1998 | 113 | 0.150 |
Why?
|
Proglumide | 1 | 1997 | 3 | 0.150 |
Why?
|
Ammonia | 2 | 2014 | 239 | 0.150 |
Why?
|
Cyclic GMP | 3 | 2015 | 409 | 0.150 |
Why?
|
Zona Reticularis | 1 | 2017 | 8 | 0.150 |
Why?
|
Hepatocyte Growth Factor | 1 | 1999 | 270 | 0.150 |
Why?
|
Receptors, Cholecystokinin | 1 | 1997 | 18 | 0.150 |
Why?
|
Pancreatic Neoplasms | 11 | 2009 | 5263 | 0.150 |
Why?
|
Stomach | 2 | 1999 | 697 | 0.150 |
Why?
|
Metformin | 3 | 2018 | 836 | 0.150 |
Why?
|
Enzyme Inhibitors | 7 | 2015 | 3799 | 0.150 |
Why?
|
Estrogens | 2 | 2014 | 1566 | 0.150 |
Why?
|
Aorta, Thoracic | 2 | 2021 | 1084 | 0.140 |
Why?
|
Natriuretic Peptides | 1 | 2018 | 150 | 0.140 |
Why?
|
Peptic Ulcer | 1 | 1998 | 223 | 0.140 |
Why?
|
Atherosclerosis | 2 | 2024 | 3444 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 599 | 0.140 |
Why?
|
Sex Characteristics | 2 | 2021 | 2585 | 0.140 |
Why?
|
Albuminuria | 3 | 2019 | 681 | 0.140 |
Why?
|
Hypothyroidism | 1 | 2021 | 658 | 0.140 |
Why?
|
Calcitriol | 1 | 2018 | 297 | 0.140 |
Why?
|
Mice, Obese | 2 | 2015 | 425 | 0.140 |
Why?
|
Pancreatic Polypeptide | 1 | 1995 | 34 | 0.140 |
Why?
|
PPAR gamma | 2 | 2010 | 493 | 0.140 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 1998 | 306 | 0.140 |
Why?
|
Bile | 5 | 1997 | 299 | 0.140 |
Why?
|
Endothelin-1 | 1 | 2017 | 314 | 0.140 |
Why?
|
Cyclic AMP | 3 | 1992 | 1472 | 0.140 |
Why?
|
Neurons, Afferent | 1 | 1998 | 506 | 0.130 |
Why?
|
Body Composition | 3 | 2020 | 2402 | 0.130 |
Why?
|
Adrenal Cortex | 2 | 1994 | 140 | 0.130 |
Why?
|
Caffeine | 1 | 2000 | 699 | 0.130 |
Why?
|
Membrane Glycoproteins | 3 | 2021 | 3771 | 0.130 |
Why?
|
Reflex, Abnormal | 1 | 2015 | 85 | 0.130 |
Why?
|
Cell Adhesion | 2 | 2021 | 3144 | 0.130 |
Why?
|
Dinoprost | 1 | 1995 | 138 | 0.130 |
Why?
|
Thyroid Gland | 2 | 2021 | 1173 | 0.130 |
Why?
|
Aortic Diseases | 1 | 2021 | 743 | 0.130 |
Why?
|
Bradykinin | 1 | 1995 | 214 | 0.130 |
Why?
|
Hyperlipidemias | 1 | 2020 | 789 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2007 | 3338 | 0.130 |
Why?
|
Ovariectomy | 2 | 2008 | 661 | 0.130 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2015 | 109 | 0.130 |
Why?
|
Liver Cirrhosis, Alcoholic | 3 | 2002 | 65 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2200 | 0.130 |
Why?
|
Delta Rhythm | 1 | 2015 | 78 | 0.130 |
Why?
|
Alpha Rhythm | 1 | 2015 | 120 | 0.130 |
Why?
|
Chemokine CCL2 | 2 | 2016 | 619 | 0.120 |
Why?
|
Blood Flow Velocity | 1 | 2018 | 1423 | 0.120 |
Why?
|
Activity Cycles | 1 | 2014 | 51 | 0.120 |
Why?
|
Prospective Studies | 16 | 2023 | 53290 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2014 | 1516 | 0.120 |
Why?
|
Lipocalins | 1 | 2015 | 170 | 0.120 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 1995 | 80 | 0.120 |
Why?
|
Lactic Acid | 4 | 2009 | 1132 | 0.120 |
Why?
|
Stimulation, Chemical | 2 | 2010 | 326 | 0.120 |
Why?
|
Protein Kinase C | 4 | 1999 | 1227 | 0.120 |
Why?
|
Steroid Hydroxylases | 1 | 1993 | 96 | 0.120 |
Why?
|
Punctures | 1 | 1995 | 374 | 0.120 |
Why?
|
Gallbladder | 1 | 1995 | 302 | 0.110 |
Why?
|
Glucagon | 5 | 1998 | 533 | 0.110 |
Why?
|
Indoles | 2 | 1999 | 1839 | 0.110 |
Why?
|
Receptors, Estrogen | 2 | 2014 | 2190 | 0.110 |
Why?
|
Angiotensin I | 1 | 2013 | 57 | 0.110 |
Why?
|
Lithotripsy | 1 | 1994 | 144 | 0.110 |
Why?
|
Captopril | 1 | 2013 | 272 | 0.110 |
Why?
|
Crohn Disease | 6 | 2003 | 2304 | 0.110 |
Why?
|
Hypothalamus | 2 | 1998 | 1063 | 0.110 |
Why?
|
Sodium-Bicarbonate Symporters | 1 | 2012 | 32 | 0.110 |
Why?
|
3T3-L1 Cells | 2 | 2015 | 199 | 0.110 |
Why?
|
Muscle Relaxation | 2 | 2010 | 142 | 0.110 |
Why?
|
Nitric Oxide Synthase | 3 | 2010 | 915 | 0.110 |
Why?
|
Pancreatin | 1 | 1992 | 9 | 0.110 |
Why?
|
Stress, Physiological | 3 | 2012 | 1403 | 0.110 |
Why?
|
Amelogenin | 1 | 2012 | 15 | 0.110 |
Why?
|
Mannose-Binding Protein-Associated Serine Proteases | 1 | 2012 | 21 | 0.100 |
Why?
|
Postprandial Period | 2 | 2012 | 292 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 3 | 2018 | 4554 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2000 | 1161 | 0.100 |
Why?
|
Poly A | 1 | 1992 | 185 | 0.100 |
Why?
|
Calorimetry, Indirect | 2 | 2010 | 183 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2596 | 0.100 |
Why?
|
Sodium Chloride | 2 | 2000 | 625 | 0.100 |
Why?
|
Diabetic Neuropathies | 1 | 1995 | 400 | 0.100 |
Why?
|
Caveolin 3 | 1 | 2011 | 25 | 0.100 |
Why?
|
Fumarates | 1 | 2012 | 132 | 0.100 |
Why?
|
Diet | 5 | 2020 | 7937 | 0.100 |
Why?
|
Pituitary Gland, Anterior | 2 | 1990 | 177 | 0.100 |
Why?
|
Muscle, Skeletal | 2 | 2013 | 4925 | 0.100 |
Why?
|
Genotype | 11 | 2021 | 12952 | 0.100 |
Why?
|
Sleep Stages | 1 | 2015 | 686 | 0.100 |
Why?
|
Energy Intake | 1 | 1999 | 2148 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2012 | 6366 | 0.100 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2013 | 365 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2014 | 6489 | 0.100 |
Why?
|
Glucose Tolerance Test | 2 | 2012 | 1151 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2355 | 0.090 |
Why?
|
Kinetics | 7 | 1999 | 6476 | 0.090 |
Why?
|
Mannose-Binding Lectin | 1 | 2012 | 150 | 0.090 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2016 | 740 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2019 | 2110 | 0.090 |
Why?
|
Gene Expression | 7 | 2021 | 7798 | 0.090 |
Why?
|
Mice, Inbred C57BL | 9 | 2021 | 21833 | 0.090 |
Why?
|
Transcription, Genetic | 7 | 2021 | 7721 | 0.090 |
Why?
|
Duodenogastric Reflux | 1 | 2009 | 5 | 0.090 |
Why?
|
Regeneration | 1 | 1999 | 1485 | 0.090 |
Why?
|
Arginine | 4 | 1998 | 944 | 0.090 |
Why?
|
Antibodies | 1 | 1998 | 2460 | 0.090 |
Why?
|
Models, Neurological | 2 | 2015 | 1775 | 0.090 |
Why?
|
Amides | 1 | 2012 | 459 | 0.090 |
Why?
|
Pain | 4 | 2005 | 4988 | 0.090 |
Why?
|
Colitis, Ulcerative | 2 | 1999 | 1911 | 0.090 |
Why?
|
Data Mining | 1 | 2014 | 537 | 0.090 |
Why?
|
Wakefulness | 2 | 2010 | 1245 | 0.090 |
Why?
|
Projection | 1 | 1989 | 18 | 0.090 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2009 | 79 | 0.090 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18034 | 0.090 |
Why?
|
Immediate-Early Proteins | 1 | 2012 | 453 | 0.090 |
Why?
|
Thalamus | 1 | 2015 | 1023 | 0.090 |
Why?
|
Germany | 6 | 2009 | 862 | 0.080 |
Why?
|
Basal Metabolism | 1 | 2010 | 168 | 0.080 |
Why?
|
Calcium | 3 | 1999 | 5755 | 0.080 |
Why?
|
Phenylephrine | 3 | 2015 | 301 | 0.080 |
Why?
|
Tumor Cells, Cultured | 11 | 2001 | 6313 | 0.080 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2010 | 769 | 0.080 |
Why?
|
Contrast Media | 4 | 2013 | 5300 | 0.080 |
Why?
|
Necrosis | 3 | 2000 | 1643 | 0.080 |
Why?
|
Pain Threshold | 1 | 2012 | 584 | 0.080 |
Why?
|
Administration, Intranasal | 1 | 2009 | 446 | 0.080 |
Why?
|
Polymerase Chain Reaction | 6 | 2014 | 6171 | 0.080 |
Why?
|
Infusions, Intravenous | 5 | 2007 | 2274 | 0.080 |
Why?
|
Bile Acids and Salts | 3 | 2003 | 368 | 0.080 |
Why?
|
Polymorphism, Genetic | 5 | 2011 | 4328 | 0.080 |
Why?
|
United States | 4 | 2023 | 69872 | 0.080 |
Why?
|
Hyperalgesia | 1 | 2012 | 502 | 0.080 |
Why?
|
Protein Kinase C-delta | 1 | 2008 | 123 | 0.080 |
Why?
|
U937 Cells | 2 | 2021 | 268 | 0.080 |
Why?
|
Parasympathetic Nervous System | 1 | 2008 | 141 | 0.080 |
Why?
|
Trimipramine | 1 | 2007 | 3 | 0.080 |
Why?
|
Lipids | 3 | 2018 | 3307 | 0.080 |
Why?
|
Premenopause | 2 | 2003 | 1033 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2012 | 3084 | 0.080 |
Why?
|
Finasteride | 1 | 2008 | 90 | 0.080 |
Why?
|
Saliva | 1 | 2012 | 809 | 0.080 |
Why?
|
Electrocardiography | 2 | 2013 | 6442 | 0.080 |
Why?
|
Estrogen Receptor alpha | 2 | 2014 | 577 | 0.080 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1534 | 0.080 |
Why?
|
Time Factors | 13 | 2020 | 40075 | 0.080 |
Why?
|
Sex Distribution | 3 | 2009 | 2297 | 0.070 |
Why?
|
Blotting, Western | 7 | 2014 | 5181 | 0.070 |
Why?
|
Glutathione Peroxidase | 1 | 2008 | 255 | 0.070 |
Why?
|
Cholecystectomy | 1 | 2009 | 395 | 0.070 |
Why?
|
Leukotriene D4 | 2 | 1997 | 38 | 0.070 |
Why?
|
Portal Vein | 3 | 1999 | 437 | 0.070 |
Why?
|
Perfusion | 3 | 2023 | 1360 | 0.070 |
Why?
|
Saline Solution, Hypertonic | 1 | 1987 | 110 | 0.070 |
Why?
|
Parathyroid Hormone | 1 | 2013 | 1800 | 0.070 |
Why?
|
Psychoanalytic Therapy | 1 | 1989 | 230 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2010 | 620 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2011 | 687 | 0.070 |
Why?
|
Systole | 2 | 2006 | 958 | 0.070 |
Why?
|
Epididymis | 1 | 2008 | 227 | 0.070 |
Why?
|
Atrial Natriuretic Factor | 2 | 1998 | 393 | 0.070 |
Why?
|
Veins | 1 | 2011 | 770 | 0.070 |
Why?
|
Heterozygote | 2 | 2012 | 2804 | 0.070 |
Why?
|
Renal Circulation | 1 | 2007 | 334 | 0.070 |
Why?
|
Streptozocin | 1 | 2006 | 196 | 0.070 |
Why?
|
Symporters | 1 | 2009 | 361 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2024 | 63107 | 0.070 |
Why?
|
Body Constitution | 2 | 1998 | 278 | 0.070 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2007 | 189 | 0.070 |
Why?
|
Arteries | 1 | 2011 | 1119 | 0.070 |
Why?
|
Regional Blood Flow | 2 | 2007 | 1525 | 0.070 |
Why?
|
Dexamethasone | 3 | 1994 | 1951 | 0.070 |
Why?
|
Object Attachment | 1 | 1989 | 313 | 0.070 |
Why?
|
Models, Biological | 5 | 2011 | 9584 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2008 | 596 | 0.070 |
Why?
|
Cells, Cultured | 9 | 2021 | 19233 | 0.070 |
Why?
|
Prolactin | 2 | 1999 | 669 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 6 | 2015 | 35425 | 0.070 |
Why?
|
Receptors, Chemokine | 1 | 2009 | 670 | 0.070 |
Why?
|
Enema | 2 | 2003 | 141 | 0.070 |
Why?
|
Phosphorylation | 6 | 2019 | 8436 | 0.070 |
Why?
|
Environment | 1 | 2011 | 1123 | 0.060 |
Why?
|
Vasodilator Agents | 5 | 2011 | 976 | 0.060 |
Why?
|
Progesterone | 2 | 2007 | 775 | 0.060 |
Why?
|
Intestine, Small | 2 | 2003 | 1240 | 0.060 |
Why?
|
Tetradecanoylphorbol Acetate | 4 | 1999 | 821 | 0.060 |
Why?
|
Age Distribution | 2 | 2009 | 2902 | 0.060 |
Why?
|
Enzyme Activation | 7 | 2001 | 3702 | 0.060 |
Why?
|
Ribosomal Protein S6 Kinases | 3 | 2000 | 205 | 0.060 |
Why?
|
Blotting, Northern | 6 | 1999 | 1581 | 0.060 |
Why?
|
Proteins | 3 | 2012 | 6100 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2013 | 3207 | 0.060 |
Why?
|
Acute Disease | 6 | 1999 | 7147 | 0.060 |
Why?
|
Forearm | 1 | 2007 | 409 | 0.060 |
Why?
|
Osteopontin | 1 | 2006 | 294 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1865 | 0.060 |
Why?
|
Case-Control Studies | 8 | 2012 | 21748 | 0.060 |
Why?
|
Genetic Variation | 2 | 2011 | 6542 | 0.060 |
Why?
|
Corticosterone | 2 | 2017 | 310 | 0.060 |
Why?
|
Hypertrophy | 1 | 2006 | 569 | 0.060 |
Why?
|
Neoplasm Proteins | 4 | 2009 | 3707 | 0.060 |
Why?
|
Gastrointestinal Agents | 2 | 1999 | 494 | 0.060 |
Why?
|
Postmenopause | 2 | 2007 | 2460 | 0.060 |
Why?
|
Citalopram | 1 | 2007 | 403 | 0.060 |
Why?
|
Wine | 1 | 2004 | 165 | 0.060 |
Why?
|
Sensitivity and Specificity | 7 | 2003 | 14723 | 0.060 |
Why?
|
Adrenergic alpha-Agonists | 2 | 2002 | 177 | 0.060 |
Why?
|
Carbon Isotopes | 3 | 2002 | 467 | 0.060 |
Why?
|
Molecular Sequence Data | 11 | 2010 | 18111 | 0.060 |
Why?
|
Aerospace Medicine | 1 | 2004 | 84 | 0.060 |
Why?
|
Exercise | 1 | 2000 | 5615 | 0.060 |
Why?
|
Muscle Proteins | 1 | 2009 | 1158 | 0.060 |
Why?
|
Cyclin D1 | 3 | 2001 | 463 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2021 | 4266 | 0.060 |
Why?
|
Base Sequence | 12 | 1998 | 12797 | 0.060 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3646 | 0.060 |
Why?
|
Microdialysis | 2 | 2002 | 158 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 857 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2007 | 711 | 0.060 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2003 | 30 | 0.060 |
Why?
|
G1 Phase | 2 | 2001 | 415 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4424 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9647 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 25039 | 0.060 |
Why?
|
Cell Membrane | 2 | 2011 | 3749 | 0.060 |
Why?
|
Catecholamines | 3 | 1995 | 387 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15078 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2021 | 4208 | 0.050 |
Why?
|
Menstrual Cycle | 1 | 2006 | 551 | 0.050 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2024 | 194 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.050 |
Why?
|
Octopamine | 1 | 2002 | 40 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 4751 | 0.050 |
Why?
|
Glucocorticoids | 1 | 1992 | 2108 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2002 | 47 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 782 | 0.050 |
Why?
|
Lipogenesis | 1 | 2024 | 212 | 0.050 |
Why?
|
Guanine Nucleotides | 1 | 1982 | 68 | 0.050 |
Why?
|
Phentolamine | 2 | 1999 | 104 | 0.050 |
Why?
|
Longevity | 1 | 2010 | 1071 | 0.050 |
Why?
|
Secretory Pathway | 1 | 2021 | 52 | 0.050 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2022 | 127 | 0.050 |
Why?
|
Chromogranins | 2 | 2000 | 160 | 0.050 |
Why?
|
Cycloheximide | 2 | 1992 | 347 | 0.050 |
Why?
|
Guanylate Cyclase | 2 | 2013 | 201 | 0.050 |
Why?
|
Phenotype | 8 | 2014 | 16367 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2010 | 1148 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 3 | 2001 | 2850 | 0.050 |
Why?
|
Response Elements | 1 | 2003 | 312 | 0.050 |
Why?
|
Edema | 3 | 2010 | 789 | 0.050 |
Why?
|
Phenylalanine | 1 | 2002 | 365 | 0.050 |
Why?
|
DNA, Complementary | 3 | 1999 | 2050 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 1998 | 4262 | 0.050 |
Why?
|
Amlodipine | 1 | 2021 | 83 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 9955 | 0.050 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2021 | 102 | 0.050 |
Why?
|
Prognosis | 7 | 2021 | 29060 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 464 | 0.050 |
Why?
|
Sampling Studies | 1 | 2002 | 623 | 0.050 |
Why?
|
Thyroid Function Tests | 1 | 2021 | 286 | 0.050 |
Why?
|
Echocardiography | 1 | 2013 | 5099 | 0.050 |
Why?
|
Probability | 2 | 2004 | 2506 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2001 | 336 | 0.050 |
Why?
|
Epoxide Hydrolases | 1 | 2021 | 122 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5096 | 0.050 |
Why?
|
Nucleic Acid Conformation | 3 | 2015 | 913 | 0.050 |
Why?
|
Metaproterenol | 1 | 1999 | 3 | 0.040 |
Why?
|
NF-kappa B | 2 | 1999 | 2499 | 0.040 |
Why?
|
Leptin | 1 | 2008 | 1600 | 0.040 |
Why?
|
Propranolol | 2 | 1999 | 502 | 0.040 |
Why?
|
Algorithms | 3 | 2015 | 13882 | 0.040 |
Why?
|
Iodide Peroxidase | 1 | 2021 | 293 | 0.040 |
Why?
|
Attention | 1 | 2010 | 2397 | 0.040 |
Why?
|
omega-N-Methylarginine | 2 | 1997 | 111 | 0.040 |
Why?
|
Lipopolysaccharides | 3 | 2003 | 2216 | 0.040 |
Why?
|
Plasmids | 5 | 1999 | 2308 | 0.040 |
Why?
|
Adrenergic Agents | 1 | 1999 | 70 | 0.040 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1999 | 54 | 0.040 |
Why?
|
Chronic Disease | 5 | 1999 | 9145 | 0.040 |
Why?
|
Cytokines | 2 | 2017 | 7323 | 0.040 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2001 | 472 | 0.040 |
Why?
|
Sleep | 4 | 2020 | 4622 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2001 | 8432 | 0.040 |
Why?
|
Age Factors | 4 | 2019 | 18373 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39052 | 0.040 |
Why?
|
Protein Kinases | 2 | 1999 | 1640 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2001 | 372 | 0.040 |
Why?
|
Carcinoid Tumor | 1 | 2000 | 235 | 0.040 |
Why?
|
Octreotide | 1 | 1999 | 145 | 0.040 |
Why?
|
Carbohydrate Metabolism | 1 | 2020 | 265 | 0.040 |
Why?
|
Isoindoles | 1 | 1998 | 41 | 0.040 |
Why?
|
Trypsinogen | 1 | 1998 | 86 | 0.040 |
Why?
|
Fibrinogens, Abnormal | 1 | 1998 | 10 | 0.040 |
Why?
|
Trypsin Inhibitor, Kunitz Soybean | 1 | 1998 | 11 | 0.040 |
Why?
|
Amino Acid Sequence | 8 | 2010 | 13814 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2002 | 633 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 5035 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2002 | 1150 | 0.040 |
Why?
|
Serum | 1 | 2019 | 214 | 0.040 |
Why?
|
Workload | 1 | 2004 | 849 | 0.040 |
Why?
|
Enzyme Stability | 1 | 2018 | 210 | 0.040 |
Why?
|
Fluoresceins | 1 | 1998 | 235 | 0.040 |
Why?
|
Proteoglycans | 1 | 2001 | 837 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2009 | 1636 | 0.040 |
Why?
|
Dehydroepiandrosterone | 1 | 1999 | 252 | 0.040 |
Why?
|
Phosphoserine | 1 | 2018 | 206 | 0.040 |
Why?
|
Urease | 1 | 1997 | 42 | 0.040 |
Why?
|
Oxides | 1 | 2000 | 405 | 0.040 |
Why?
|
Thigh | 1 | 1999 | 247 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4216 | 0.040 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2017 | 57 | 0.040 |
Why?
|
Sulfasalazine | 1 | 1998 | 79 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2008 | 3690 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2000 | 374 | 0.040 |
Why?
|
5-Methylcytosine | 1 | 2018 | 154 | 0.040 |
Why?
|
Receptors, Growth Factor | 1 | 1999 | 334 | 0.040 |
Why?
|
Pyloric Antrum | 1 | 1997 | 69 | 0.040 |
Why?
|
Body Temperature | 1 | 2001 | 777 | 0.040 |
Why?
|
Trypsin | 1 | 1998 | 511 | 0.040 |
Why?
|
Sulfones | 1 | 2020 | 436 | 0.040 |
Why?
|
DNA | 3 | 2018 | 7294 | 0.040 |
Why?
|
Sensory Thresholds | 1 | 1999 | 391 | 0.040 |
Why?
|
Fatigue | 1 | 2005 | 1531 | 0.040 |
Why?
|
Indicators and Reagents | 1 | 1998 | 462 | 0.040 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 86 | 0.040 |
Why?
|
Sincalide | 1 | 1997 | 16 | 0.040 |
Why?
|
Diet Records | 1 | 1999 | 425 | 0.040 |
Why?
|
Taurocholic Acid | 1 | 1997 | 43 | 0.040 |
Why?
|
Cholagogues and Choleretics | 1 | 1997 | 32 | 0.040 |
Why?
|
Losartan | 1 | 1999 | 299 | 0.040 |
Why?
|
Intestinal Neoplasms | 1 | 2000 | 319 | 0.040 |
Why?
|
Gastrins | 1 | 1997 | 81 | 0.040 |
Why?
|
Substance P | 1 | 1998 | 335 | 0.040 |
Why?
|
Reflex | 1 | 1999 | 365 | 0.040 |
Why?
|
Incidence | 2 | 2013 | 20952 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 1998 | 139 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6234 | 0.040 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1999 | 437 | 0.040 |
Why?
|
Growth Substances | 1 | 1999 | 784 | 0.040 |
Why?
|
Adrenocortical Hyperfunction | 1 | 2016 | 14 | 0.040 |
Why?
|
Aldehyde Reductase | 1 | 2016 | 65 | 0.040 |
Why?
|
Protein Binding | 4 | 2014 | 9384 | 0.040 |
Why?
|
Fasting | 2 | 2011 | 1592 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1997 | 719 | 0.040 |
Why?
|
Serine Proteinase Inhibitors | 1 | 1998 | 179 | 0.040 |
Why?
|
Posture | 1 | 2001 | 958 | 0.040 |
Why?
|
Overweight | 2 | 2024 | 2371 | 0.040 |
Why?
|
Bacteriological Techniques | 1 | 1997 | 277 | 0.040 |
Why?
|
Endoscopy, Digestive System | 2 | 1999 | 345 | 0.040 |
Why?
|
Dioxygenases | 1 | 2018 | 316 | 0.030 |
Why?
|
Pregnancy | 2 | 2018 | 29144 | 0.030 |
Why?
|
Genes, ras | 1 | 1999 | 690 | 0.030 |
Why?
|
Minerals | 1 | 2018 | 275 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2006 | 489 | 0.030 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 93 | 0.030 |
Why?
|
Cohort Studies | 5 | 2021 | 40559 | 0.030 |
Why?
|
Protein Biosynthesis | 3 | 1998 | 2126 | 0.030 |
Why?
|
Enteric Nervous System | 1 | 1999 | 189 | 0.030 |
Why?
|
Dipeptides | 1 | 1998 | 409 | 0.030 |
Why?
|
Labetalol | 1 | 1995 | 30 | 0.030 |
Why?
|
Transcription Factors | 4 | 2003 | 12207 | 0.030 |
Why?
|
Resistin | 1 | 2016 | 170 | 0.030 |
Why?
|
Food | 1 | 2001 | 772 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2004 | 1469 | 0.030 |
Why?
|
Host-Parasite Interactions | 1 | 1998 | 295 | 0.030 |
Why?
|
Citric Acid | 1 | 1996 | 126 | 0.030 |
Why?
|
HIV-1 | 2 | 2015 | 6939 | 0.030 |
Why?
|
Dibenzocycloheptenes | 1 | 2015 | 27 | 0.030 |
Why?
|
Mutation | 5 | 2012 | 29786 | 0.030 |
Why?
|
Neurons | 1 | 2015 | 9340 | 0.030 |
Why?
|
Electric Impedance | 1 | 1999 | 729 | 0.030 |
Why?
|
Mice, Nude | 2 | 2018 | 3689 | 0.030 |
Why?
|
Pressure | 1 | 1999 | 1203 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 504 | 0.030 |
Why?
|
Cattle | 4 | 1996 | 3922 | 0.030 |
Why?
|
Nitrites | 1 | 1995 | 160 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 1997 | 658 | 0.030 |
Why?
|
Peptic Ulcer Hemorrhage | 1 | 1995 | 49 | 0.030 |
Why?
|
Sodium Oxybate | 1 | 2015 | 32 | 0.030 |
Why?
|
Melatonin | 1 | 2001 | 721 | 0.030 |
Why?
|
Indocyanine Green | 1 | 1997 | 239 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2016 | 0.030 |
Why?
|
Duodenal Ulcer | 1 | 1995 | 125 | 0.030 |
Why?
|
Genes, MHC Class II | 1 | 1996 | 457 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 302 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 294 | 0.030 |
Why?
|
Stomach Ulcer | 1 | 1995 | 125 | 0.030 |
Why?
|
Pancreatic Function Tests | 1 | 1995 | 69 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 3 | 1999 | 1375 | 0.030 |
Why?
|
Fibrin Tissue Adhesive | 1 | 1995 | 85 | 0.030 |
Why?
|
Models, Statistical | 2 | 2015 | 5101 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2000 | 1031 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 1999 | 913 | 0.030 |
Why?
|
Bone Diseases, Metabolic | 1 | 1999 | 417 | 0.030 |
Why?
|
Lactates | 1 | 1995 | 432 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2015 | 475 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 10895 | 0.030 |
Why?
|
p-Aminohippuric Acid | 1 | 2014 | 36 | 0.030 |
Why?
|
Light | 1 | 2001 | 1374 | 0.030 |
Why?
|
Adipocytes, White | 1 | 2015 | 89 | 0.030 |
Why?
|
Gallbladder Emptying | 1 | 1994 | 15 | 0.030 |
Why?
|
Chromaffin System | 1 | 1994 | 16 | 0.030 |
Why?
|
Nitroglycerin | 1 | 1995 | 325 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 1999 | 612 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2014 | 220 | 0.030 |
Why?
|
Neuroendocrine Tumors | 1 | 2000 | 594 | 0.030 |
Why?
|
Rabbits | 3 | 2011 | 4894 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 1996 | 645 | 0.030 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1994 | 98 | 0.030 |
Why?
|
Pregnenolone | 1 | 1993 | 26 | 0.030 |
Why?
|
Androstenedione | 1 | 1994 | 131 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2018 | 1802 | 0.030 |
Why?
|
Crystallization | 1 | 1995 | 525 | 0.030 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 1993 | 30 | 0.030 |
Why?
|
Steroid 11-beta-Hydroxylase | 1 | 1993 | 20 | 0.030 |
Why?
|
Pilot Projects | 1 | 2007 | 8319 | 0.030 |
Why?
|
Benzimidazoles | 1 | 1999 | 850 | 0.030 |
Why?
|
Transfection | 3 | 1998 | 5895 | 0.030 |
Why?
|
Rats, Inbred WKY | 1 | 1993 | 158 | 0.030 |
Why?
|
NAD | 1 | 2017 | 590 | 0.030 |
Why?
|
Family Health | 1 | 1999 | 1281 | 0.030 |
Why?
|
Pyrroles | 1 | 2020 | 1146 | 0.030 |
Why?
|
Receptors, Leptin | 1 | 2015 | 361 | 0.030 |
Why?
|
Tetrazoles | 1 | 1999 | 835 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2014 | 2646 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1995 | 963 | 0.030 |
Why?
|
Cell Line | 6 | 2001 | 16000 | 0.030 |
Why?
|
Heart Injuries | 1 | 2015 | 210 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2016 | 293 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 1999 | 923 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 2 | 2012 | 850 | 0.030 |
Why?
|
Abdomen | 1 | 1999 | 1118 | 0.030 |
Why?
|
Endotoxins | 1 | 1995 | 527 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 1999 | 2887 | 0.030 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 2076 | 0.030 |
Why?
|
Hypoaldosteronism | 1 | 1992 | 8 | 0.030 |
Why?
|
Odds Ratio | 2 | 2012 | 9849 | 0.030 |
Why?
|
Imidazoles | 1 | 1999 | 1206 | 0.030 |
Why?
|
Postoperative Period | 1 | 1998 | 1842 | 0.030 |
Why?
|
Linear Models | 2 | 2014 | 5953 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1995 | 1681 | 0.030 |
Why?
|
Prevalence | 5 | 2016 | 15221 | 0.030 |
Why?
|
Anisomycin | 1 | 1992 | 28 | 0.030 |
Why?
|
Radioimmunoassay | 2 | 1990 | 919 | 0.030 |
Why?
|
Neoplasms | 2 | 2018 | 21696 | 0.030 |
Why?
|
Image Enhancement | 1 | 2003 | 2921 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2003 | 2148 | 0.030 |
Why?
|
Antigens | 1 | 1998 | 1466 | 0.030 |
Why?
|
Xenopus | 1 | 2014 | 712 | 0.030 |
Why?
|
Perception | 1 | 1999 | 1198 | 0.030 |
Why?
|
Point Mutation | 1 | 1997 | 1624 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2010 | 57776 | 0.030 |
Why?
|
Insulin-Secreting Cells | 1 | 2020 | 892 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2003 | 3037 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 638 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 480 | 0.030 |
Why?
|
Biological Transport | 1 | 1997 | 2120 | 0.030 |
Why?
|
Vitamin D | 2 | 2018 | 3224 | 0.030 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 361 | 0.030 |
Why?
|
DNA Replication | 3 | 1984 | 1399 | 0.030 |
Why?
|
Thymine | 1 | 2012 | 68 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1992 | 192 | 0.030 |
Why?
|
Sirolimus | 1 | 1999 | 1565 | 0.030 |
Why?
|
Blood Vessels | 1 | 2018 | 1125 | 0.030 |
Why?
|
Cloning, Molecular | 4 | 1998 | 4320 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3966 | 0.030 |
Why?
|
Subcutaneous Fat | 1 | 2015 | 391 | 0.030 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2011 | 16 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12244 | 0.030 |
Why?
|
Parathyroid Glands | 1 | 2013 | 509 | 0.030 |
Why?
|
Genes | 2 | 1999 | 1893 | 0.030 |
Why?
|
Aerosols | 1 | 2014 | 625 | 0.030 |
Why?
|
Trans-Activators | 1 | 2001 | 2926 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2014 | 906 | 0.020 |
Why?
|
Cell Cycle Proteins | 2 | 2001 | 3464 | 0.020 |
Why?
|
Iron | 1 | 2000 | 1774 | 0.020 |
Why?
|
Metabolome | 1 | 2018 | 895 | 0.020 |
Why?
|
Guanine | 1 | 2012 | 274 | 0.020 |
Why?
|
Cytosine | 1 | 2012 | 216 | 0.020 |
Why?
|
Carrier Proteins | 2 | 2001 | 5023 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3554 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2015 | 9735 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 610 | 0.020 |
Why?
|
Pedigree | 1 | 1998 | 4642 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 2 | 2013 | 1988 | 0.020 |
Why?
|
Blood Proteins | 2 | 1999 | 1124 | 0.020 |
Why?
|
Anthropometry | 1 | 1995 | 1350 | 0.020 |
Why?
|
S Phase | 2 | 2001 | 423 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1998 | 1988 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9445 | 0.020 |
Why?
|
Logistic Models | 3 | 2012 | 13409 | 0.020 |
Why?
|
Molecular Structure | 1 | 2014 | 1899 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2007 | 4639 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2001 | 323 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 25628 | 0.020 |
Why?
|
Saponins | 1 | 1989 | 50 | 0.020 |
Why?
|
Subcellular Fractions | 2 | 2001 | 547 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1121 | 0.020 |
Why?
|
Freudian Theory | 1 | 1989 | 34 | 0.020 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2008 | 21 | 0.020 |
Why?
|
Osteoporosis | 1 | 1999 | 1579 | 0.020 |
Why?
|
Nutritional Status | 1 | 2017 | 1609 | 0.020 |
Why?
|
Recombination, Genetic | 2 | 1998 | 1586 | 0.020 |
Why?
|
Eating | 1 | 1995 | 1536 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2000 | 1912 | 0.020 |
Why?
|
Digoxin | 1 | 1989 | 250 | 0.020 |
Why?
|
Ileum | 2 | 2003 | 565 | 0.020 |
Why?
|
Diabetes Complications | 1 | 1995 | 1359 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2009 | 15297 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2004 | 13991 | 0.020 |
Why?
|
Bacteriophage lambda | 1 | 1988 | 147 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1996 | 4933 | 0.020 |
Why?
|
Transcriptional Activation | 3 | 2001 | 1783 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 2008 | 190 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1998 | 1790 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 1997 | 1903 | 0.020 |
Why?
|
Acetylcholine | 1 | 2010 | 621 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2011 | 532 | 0.020 |
Why?
|
Feedback | 1 | 1992 | 795 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2009 | 212 | 0.020 |
Why?
|
Endothelial Cells | 2 | 2011 | 3486 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 494 | 0.020 |
Why?
|
Action Potentials | 1 | 2015 | 1806 | 0.020 |
Why?
|
Cell Division | 3 | 2000 | 4569 | 0.020 |
Why?
|
Chromogranin A | 2 | 2000 | 54 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2428 | 0.020 |
Why?
|
Infant | 1 | 2010 | 35134 | 0.020 |
Why?
|
Isometric Contraction | 1 | 2008 | 143 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 1988 | 476 | 0.020 |
Why?
|
Carcinoma | 1 | 1999 | 2375 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1342 | 0.020 |
Why?
|
Pro-Opiomelanocortin | 1 | 1988 | 163 | 0.020 |
Why?
|
Immunohistochemistry | 4 | 2011 | 11366 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2008 | 262 | 0.020 |
Why?
|
Genetics, Medical | 1 | 2010 | 338 | 0.020 |
Why?
|
Chick Embryo | 1 | 2009 | 982 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2001 | 644 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1997 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3848 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2002 | 15535 | 0.020 |
Why?
|
Transcription Factor AP-1 | 2 | 1999 | 317 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 1999 | 8300 | 0.020 |
Why?
|
Piperidines | 1 | 2015 | 1602 | 0.020 |
Why?
|
Staphylococcus aureus | 3 | 1984 | 1453 | 0.020 |
Why?
|
Chromosome Mapping | 4 | 1998 | 4740 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5856 | 0.020 |
Why?
|
Administration, Oral | 3 | 2000 | 3914 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2504 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2011 | 950 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2009 | 498 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 936 | 0.020 |
Why?
|
Water-Electrolyte Balance | 1 | 2007 | 346 | 0.020 |
Why?
|
Anger | 1 | 1989 | 402 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 2166 | 0.020 |
Why?
|
Antigens, CD | 1 | 2016 | 4026 | 0.020 |
Why?
|
Vasopressins | 1 | 1987 | 370 | 0.020 |
Why?
|
Bacterial Proteins | 4 | 1999 | 3854 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
Health | 1 | 2008 | 394 | 0.020 |
Why?
|
Recurrence | 2 | 1995 | 8340 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3338 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7914 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 1995 | 8642 | 0.020 |
Why?
|
Vitis | 1 | 2004 | 18 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5451 | 0.020 |
Why?
|
Coronary Disease | 1 | 1999 | 6077 | 0.020 |
Why?
|
Analgesics | 1 | 1992 | 1040 | 0.020 |
Why?
|
Growth Hormone | 1 | 1987 | 705 | 0.020 |
Why?
|
Genetic Markers | 1 | 2011 | 2634 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2007 | 936 | 0.020 |
Why?
|
Alanine | 2 | 1997 | 572 | 0.020 |
Why?
|
DNA Methylation | 1 | 2018 | 4285 | 0.020 |
Why?
|
Butylscopolammonium Bromide | 1 | 2003 | 2 | 0.010 |
Why?
|
Isoenzymes | 1 | 2008 | 1728 | 0.010 |
Why?
|
Mathematical Computing | 1 | 2003 | 147 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 2186 | 0.010 |
Why?
|
Ecdysone | 1 | 2003 | 17 | 0.010 |
Why?
|
Escherichia coli | 1 | 1995 | 4217 | 0.010 |
Why?
|
Retinoid X Receptors | 1 | 2003 | 93 | 0.010 |
Why?
|
Steroid 17-alpha-Hydroxylase | 2 | 1994 | 98 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 2003 | 380 | 0.010 |
Why?
|
Neoplasm Invasiveness | 2 | 2001 | 3616 | 0.010 |
Why?
|
Body Fluid Compartments | 1 | 2002 | 52 | 0.010 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2002 | 19 | 0.010 |
Why?
|
Gene Silencing | 1 | 2009 | 1539 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 23336 | 0.010 |
Why?
|
DNA Restriction Enzymes | 2 | 1998 | 570 | 0.010 |
Why?
|
Psychophysiologic Disorders | 1 | 2004 | 228 | 0.010 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2002 | 24 | 0.010 |
Why?
|
Brain | 1 | 2009 | 26388 | 0.010 |
Why?
|
Half-Life | 1 | 2003 | 661 | 0.010 |
Why?
|
Biglycan | 1 | 2001 | 9 | 0.010 |
Why?
|
Receptors, Retinoic Acid | 1 | 2003 | 232 | 0.010 |
Why?
|
Mathematics | 1 | 2003 | 728 | 0.010 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2002 | 361 | 0.010 |
Why?
|
Adenovirus E1A Proteins | 1 | 2001 | 76 | 0.010 |
Why?
|
Ultrasonography | 1 | 1995 | 5984 | 0.010 |
Why?
|
Pain Measurement | 1 | 1992 | 3420 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.010 |
Why?
|
Cyclin A | 1 | 2001 | 60 | 0.010 |
Why?
|
Skin Diseases | 1 | 2010 | 1066 | 0.010 |
Why?
|
Graves Disease | 1 | 1983 | 242 | 0.010 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2001 | 121 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
G2 Phase | 1 | 2001 | 139 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2001 | 300 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1998 | 9274 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 1997 | 2649 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2003 | 458 | 0.010 |
Why?
|
Central Nervous System Depressants | 1 | 2002 | 167 | 0.010 |
Why?
|
E1A-Associated p300 Protein | 1 | 2001 | 131 | 0.010 |
Why?
|
Natriuresis | 1 | 2001 | 124 | 0.010 |
Why?
|
DNA, Bacterial | 2 | 1984 | 1465 | 0.010 |
Why?
|
Child, Preschool | 4 | 2012 | 41005 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2001 | 2949 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2001 | 285 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2000 | 76 | 0.010 |
Why?
|
Radiography | 2 | 2003 | 7023 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1982 | 442 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1998 | 6364 | 0.010 |
Why?
|
Transcription Factor RelB | 1 | 1999 | 29 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3505 | 0.010 |
Why?
|
Liver Neoplasms | 2 | 1994 | 4253 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2008 | 1888 | 0.010 |
Why?
|
Calcium-Transporting ATPases | 1 | 1999 | 123 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2000 | 8038 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 1999 | 158 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 1999 | 4561 | 0.010 |
Why?
|
Barium Sulfate | 1 | 2000 | 180 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 1999 | 67 | 0.010 |
Why?
|
Placenta | 1 | 1988 | 1699 | 0.010 |
Why?
|
Beverages | 1 | 2004 | 821 | 0.010 |
Why?
|
Intestinal Fistula | 1 | 2000 | 140 | 0.010 |
Why?
|
Nucleic Acid Precursors | 1 | 1998 | 15 | 0.010 |
Why?
|
Cyclin E | 1 | 1999 | 172 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2000 | 322 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2000 | 335 | 0.010 |
Why?
|
Blood Group Antigens | 1 | 1960 | 180 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 853 | 0.010 |
Why?
|
Sulfapyridine | 1 | 1998 | 5 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16690 | 0.010 |
Why?
|
Receptor, Notch1 | 1 | 2001 | 502 | 0.010 |
Why?
|
Thiocarbamates | 1 | 1998 | 31 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4420 | 0.010 |
Why?
|
Cathepsin B | 1 | 1998 | 82 | 0.010 |
Why?
|
DNA Probes | 1 | 1999 | 560 | 0.010 |
Why?
|
Nucleotide Mapping | 1 | 1997 | 20 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 1999 | 402 | 0.010 |
Why?
|
Phorbol Esters | 1 | 1998 | 111 | 0.010 |
Why?
|
Tyrosine | 1 | 2002 | 1462 | 0.010 |
Why?
|
Wilms Tumor | 1 | 2001 | 373 | 0.010 |
Why?
|
Cell Fractionation | 1 | 1998 | 252 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 2000 | 390 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 871 | 0.010 |
Why?
|
Chelating Agents | 1 | 1999 | 380 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2006 | 2307 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.010 |
Why?
|
Cystine | 1 | 1998 | 95 | 0.010 |
Why?
|
Testosterone | 1 | 2008 | 2419 | 0.010 |
Why?
|
Vacuoles | 1 | 1998 | 229 | 0.010 |
Why?
|
Magnesium Sulfate | 1 | 1998 | 68 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 705 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2001 | 705 | 0.010 |
Why?
|
Mental Status Schedule | 1 | 1998 | 321 | 0.010 |
Why?
|
Birth Order | 1 | 1998 | 95 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 647 | 0.010 |
Why?
|
Mutagenesis | 1 | 2001 | 1264 | 0.010 |
Why?
|
Turkey | 1 | 1998 | 237 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2001 | 539 | 0.010 |
Why?
|
Portal Pressure | 1 | 1997 | 62 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2001 | 2086 | 0.010 |
Why?
|
Mesalamine | 1 | 1998 | 136 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2001 | 671 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2001 | 791 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 429 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1997 | 803 | 0.010 |
Why?
|
Deuterium | 1 | 1997 | 101 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2002 | 2184 | 0.010 |
Why?
|
Nitrogen Isotopes | 1 | 1997 | 84 | 0.010 |
Why?
|
Nitroprusside | 1 | 1997 | 275 | 0.010 |
Why?
|
Cyclosporine | 1 | 1999 | 788 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 1998 | 367 | 0.010 |
Why?
|
Apolipoprotein E4 | 1 | 2000 | 668 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1998 | 437 | 0.010 |
Why?
|
Colonic Diseases | 1 | 1998 | 202 | 0.010 |
Why?
|
Family Practice | 1 | 1999 | 516 | 0.010 |
Why?
|
Proline | 1 | 1998 | 458 | 0.010 |
Why?
|
Abscess | 1 | 2000 | 607 | 0.010 |
Why?
|
Sequence Homology | 1 | 1996 | 203 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1999 | 995 | 0.010 |
Why?
|
Chymotrypsinogen | 1 | 1975 | 5 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1999 | 1799 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2088 | 0.010 |
Why?
|
Mammals | 1 | 2001 | 1143 | 0.010 |
Why?
|
Genes, Neoplasm | 1 | 1998 | 376 | 0.010 |
Why?
|
Stromal Cells | 1 | 2001 | 1355 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1284 | 0.010 |
Why?
|
HLA-DQ Antigens | 1 | 1996 | 210 | 0.010 |
Why?
|
Virulence | 1 | 1999 | 1333 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2001 | 1115 | 0.010 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1996 | 246 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 248 | 0.010 |
Why?
|
Sequence Analysis, DNA | 2 | 1998 | 4805 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 1999 | 676 | 0.010 |
Why?
|
Introns | 1 | 1998 | 992 | 0.010 |
Why?
|
ras Proteins | 1 | 2001 | 1060 | 0.010 |
Why?
|
Gluconeogenesis | 1 | 1996 | 183 | 0.010 |
Why?
|
Ethanol | 1 | 2002 | 1342 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2002 | 2204 | 0.010 |
Why?
|
Amylases | 1 | 1975 | 173 | 0.010 |
Why?
|
HeLa Cells | 1 | 2001 | 3130 | 0.010 |
Why?
|
Carbachol | 1 | 1975 | 226 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1999 | 1547 | 0.010 |
Why?
|
Parity | 1 | 1998 | 929 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 1998 | 769 | 0.010 |
Why?
|
Comorbidity | 1 | 2009 | 10388 | 0.010 |
Why?
|
Glyburide | 1 | 1975 | 113 | 0.010 |
Why?
|
Receptors, Calcium-Sensing | 1 | 1996 | 315 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 77460 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1998 | 811 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1999 | 1235 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 1999 | 1085 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2001 | 1692 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 1999 | 1172 | 0.010 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1997 | 581 | 0.010 |
Why?
|
Leucine | 1 | 1975 | 560 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 1999 | 1470 | 0.010 |
Why?
|
Lymphocytes | 1 | 1982 | 2617 | 0.010 |
Why?
|
Placebos | 1 | 1998 | 1676 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1998 | 1663 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 1999 | 1146 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2256 | 0.010 |
Why?
|
Lysosomes | 1 | 1998 | 893 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2001 | 2383 | 0.010 |
Why?
|
Lipase | 1 | 1975 | 314 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1525 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 2716 | 0.010 |
Why?
|
Survival Rate | 2 | 1999 | 12788 | 0.010 |
Why?
|
Dietary Proteins | 1 | 1998 | 963 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3773 | 0.010 |
Why?
|
Organ Specificity | 1 | 1998 | 2008 | 0.010 |
Why?
|
Oligopeptides | 1 | 1998 | 1189 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1997 | 2839 | 0.010 |
Why?
|
Binding Sites | 1 | 2001 | 6111 | 0.010 |
Why?
|
Hydroxyurea | 1 | 1994 | 289 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1998 | 1758 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2001 | 2418 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1998 | 2971 | 0.010 |
Why?
|
Internal Medicine | 1 | 1999 | 1009 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6386 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1996 | 970 | 0.010 |
Why?
|
Piperazines | 1 | 2002 | 2488 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12262 | 0.010 |
Why?
|
Cell Cycle | 1 | 1999 | 2967 | 0.010 |
Why?
|
RNA | 1 | 2001 | 2749 | 0.010 |
Why?
|
Amino Acids | 1 | 1997 | 1737 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2000 | 2938 | 0.010 |
Why?
|
Child | 4 | 2001 | 77709 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 1998 | 974 | 0.010 |
Why?
|
Antioxidants | 1 | 1998 | 1659 | 0.010 |
Why?
|
Educational Status | 1 | 1998 | 2540 | 0.010 |
Why?
|
Cardenolides | 1 | 1989 | 20 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1101 | 0.010 |
Why?
|
Biopsy | 1 | 2001 | 6755 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1994 | 1767 | 0.010 |
Why?
|
Pancreatic Pseudocyst | 1 | 1989 | 110 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6621 | 0.000 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1988 | 103 | 0.000 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 2282 | 0.000 |
Why?
|
Genetic Testing | 1 | 2000 | 3444 | 0.000 |
Why?
|
Methotrexate | 1 | 1994 | 1728 | 0.000 |
Why?
|
Population Surveillance | 1 | 1998 | 2616 | 0.000 |
Why?
|
Aspirin | 1 | 1998 | 3283 | 0.000 |
Why?
|
Bone Density | 1 | 1999 | 3468 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 1998 | 6994 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 19905 | 0.000 |
Why?
|
Tetracycline | 1 | 1984 | 214 | 0.000 |
Why?
|
Disease Progression | 1 | 2001 | 13286 | 0.000 |
Why?
|
Swine | 1 | 1994 | 5918 | 0.000 |
Why?
|
Replicon | 1 | 1982 | 34 | 0.000 |
Why?
|
Methods | 1 | 1983 | 1129 | 0.000 |
Why?
|
Antibody Affinity | 1 | 1983 | 254 | 0.000 |
Why?
|
Fibrosis | 1 | 1989 | 2029 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1994 | 2214 | 0.000 |
Why?
|
Drug Resistance, Microbial | 1 | 1984 | 862 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1995 | 5316 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1984 | 1401 | 0.000 |
Why?
|
Gestational Age | 1 | 1988 | 3493 | 0.000 |
Why?
|